In July 2015, Praluent (alirocumab) was approved by the FDA as the first drug in a new class known as PCSK9 inhibitors. It was joined by Repatha (evolocumab), which received approval on August 27, 2015. These new injectable medications are the first approvals in a long time that may be as effective as statins—or better—at lowering cholesterol.
Praluent Latest News
Get the latest updates on this drug from the GoodRx medical team
If you have high cholesterol you likely take a statin medication (atorvastatin (Lipitor), simvastatin (Zocor), Crestor) to help you manage it. Statins have been the mainstay of treatment for high cholesterol since their initial approval in the late 1980s—and recent data from the National Health and Nutrition Examination Survey (NHANES) shows that approximately 22% of Americans 45 years of age and older now take a statin. See More